Tate & Lyle (OTC: TATYY) is a global company specializing in food ingredients like sweeteners, mouthfeel, and fortification products. A key competitor, Ingredion (NYSE: INGR), is now moving to acquire the company. This development is reshaping the landscape for specialty ingredient providers and has led to significant market activity surrounding Tate & Lyle.
On June 9, 2026, Exane BNP Paribas changed its stock rating on Tate & Lyle to Neutral. This adjustment came as the stock price was $29.85. A "Neutral" rating suggests that analysts expect the stock's performance to be average, with limited potential for major price increases or decreases from its current level.
The rating change follows major acquisition news. As highlighted by the Wall Street Journal, Ingredion is set to take over Tate & Lyle in a deal valued at $3.6 billion. The offer of $7.94 for each share represents a 59% premium over the stock's closing price before the takeover discussions became public last month.
According to Proactive Investors, shareholders will receive 595p in cash for each share. They will also keep a final dividend of up to 13.20p for the 2026 financial year and an interim dividend of up to 6.80p for the first half of the 2027 financial year.
As highlighted by GlobeNewswire, the acquisition strategy aims to create a larger global provider of specialty ingredient solutions. Ingredion plans to broaden its platform in texturants and sugar reduction. The combination will also expand its supply networks across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.
